Maryland-based biotech company Deka Biosciences (“Deka”) today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors led by Leaps by Bayer, the impact investment arm of Bayer AG, and new investor Lumira Ventures. Additional investors include O-Bio (Echo Investment Capital), Viva BioInnovator, and Alexandria Venture Investments.
Wheeler Bio announces oversubscribed Series A-1, plans for expansion and continued growth
The financing will broaden Wheeler’s capabilities, paving the way for future growth and planned build-out of a 52,000 square foot manufacturing facility.